CIAM
COLL icon

Caitong International Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Caitong International Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-635
Closed -$29.4K – 2680
2025
Q4 		$29.4K Buy
635
+427
+205% +$17.9K 0.01% 892
2025
Q3 		$7.28K Buy
208
+145
+230% +$5.04K 0.01% 1112
2025
Q2 		$1.86K Sell
63
-6
-9% -$171 ﹤0.01% 1408
2025
Q1 		$2.06K Buy
69
+49
+245% +$1.5K ﹤0.01% 1330
2024
Q4 		$573 Buy
+20
New +$662 ﹤0.01% 1438

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Caitong International Asset Management's COLL Position: Q1 2026 in Review

Caitong International Asset Management sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 635 shares — an estimated $29.4K sold.

Caitong International Asset Management first reported a position in COLL in Q4 2024 and held it in 5 quarters. The position peaked at $29.4K in Q4 2025. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Caitong International Asset Management reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 635 Collegium Pharmaceutical shares in Q1 2026, an estimated $29.4K.
  • Caitong International Asset Management first reported a position in Collegium Pharmaceutical in Q4 2024 and held it in 5 quarters.
  • Caitong International Asset Management's Collegium Pharmaceutical position peaked at $29.4K in Q4 2025.
  • 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.